India News | DGCI Nod to Covaxin for Use in Children Above 12 Years with Certain Conditions
Get latest articles and stories on India at LatestLY. The Drugs Controller General of India (DCGI) has granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions, sources said on Saturday.
New Delhi, Dec 25 (PTI) The Drugs Controller General of India (DCGI) has granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions, sources said on Saturday.
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.
Also Read | Delhi: Guinean Woman Held at Indira Gandhi International Airport With Heroin Valued at Rs 72 Crore.
"The recommendations of the SEC were evaluated by another experts committee after which DCGI had sought additional data from the firm," a source said.
The DCGI gave its approval Friday, the source said.
Also Read | Delhi’s Air Quality Recorded in ‘Severe’ Category, Light Rain Likely in City Tomorrow.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)